This promotional video series is Intended for UK healthcare professionals and has been developed and funded by Luye Pharma UK.

Zeyzelf (rivastigmine) Prescribing Information and Adverse Event Reporting Information can be found at the bottom of this website page.

Webinar and
Video Series

Explore our latest webinar and video series covering a range of topics

Already registered?

Log in to View

Register Now

Register your interest now to access the latest webinar and video content and take the first step towards expanding your expertise in dementia care.

Registration

Recorded Webinar

Improving Care Quality: A Look at Treatment Pathways

ZeyzeIf® (rivastigmine) is a twice weekly transdermal patch indicated for the symptomatic treatment of mild to moderately severe Alzheimer's dementia.

The webinar has been developed to discuss the ever increasing challenges for Improving Care Quality for Alzheimer's Patients in 2025 and to discuss how to optimise pathways between primary and secondary care.

Dr Benson Benjamin

MBBS. DCP, Mrcpsych, MSC (Neuropsychiatry)

Prof Gerard Piñol-Ripoll

Head of Unit Memory LLeida University of LLeida

Dr. Manjunadh Pillai

MBBS. MD. MRC (Psych)

Emily Kinyanjui

Clinical Nurse Specialist in Dementia Central and North West London (CNWL)

Video Series

Hosted by Dr. Delia Bishara Consultant Pharmacist

This video series reviews a range of topics relating to Alzheimer's Dementia.

Dr. Delia Bishara
BPharm, PhD, MCMHP

Consultant Pharmacist, Mental Health of Older Adults & Dementia South London & Maudsley NHS Foundation Trust.

Webinar

Treating Dementia in 2024: Chaired by Dr Jill Rasmussen

Our speakers discuss Optimising Pathways between Primary and Secondary Care.

Dr. Jill Rasmussen

Primary Care Specialist in Dementia, Mental Health and Intellectual Disability.

Mr Khaleel Loonat

Senior Clinical Pharmacist & Advanced Clinical Practitioner.

Dr. Delia Bishara